Blue Sparrow LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.2M Buy
64,400
+16,090
+33% +$16.4M 0.75% 33
2026
Q1
$44.4M Buy
48,310
+1,510
+3% +$1.53M 0.76% 23
2025
Q4
$50.3M Buy
+46,800
New +$44.7M 0.95% 22

Other funds holding LLY

Blue Sparrow LLC's LLY Position: Q2 2026 in Review

Blue Sparrow LLC increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $16.4M and bringing the position to 64,400 shares worth $77.2M. The position accounts for 0.75% of the portfolio, ranked #33.

Blue Sparrow LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blue Sparrow LLC held 64,400 shares of Eli Lilly worth $77.2M as of Q2 2026.
  • Blue Sparrow LLC bought 16,090 Eli Lilly shares in Q2 2026, an estimated $16.4M.
  • Eli Lilly made up 0.75% of Blue Sparrow LLC's portfolio in Q2 2026, its #33 holding.
  • Blue Sparrow LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blue Sparrow LLC's 13F filing for Q2 2026, filed 14 Aug 2026.